Eric Vuillemin
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 13
- Cutaneous Melanoma Detection and Management 8
- Cancer Immunotherapy and Biomarkers 2
- Cancer Treatment and Pharmacology 2
- Neutropenia and Cancer Infections 1
- Cancer survivorship and care 1
-
- Head and Neck Cancer Studies 2
- Co-authors
- Mo�se Namer (2 shared papers)D. Serin (2 shared papers)Stéphane Culine (1 shared paper)Veronique C Dieras (1 shared paper)Jean‐François Morère (1 shared paper)P. Fumoleau (1 shared paper)David Khayat (11 shared papers)François Montestruc (1 shared paper)
- Journals
- European Journal of Cancer (4 papers)Annals of Oncology (3 papers)Clinical & Experimental Immunology (2 papers)Psycho-Oncology (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- France
In The Last Decade
Eric Vuillemin
19 papers receiving 456 citations
Peers
Comparison fields: 5 of 45
- Oncology 331
- Cancer Research 109
- Biological Psychiatry 5
- Otorhinolaryngology 11
- Dermatology 15
Countries citing papers authored by Eric Vuillemin
This map shows the geographic impact of Eric Vuillemin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Vuillemin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Vuillemin more than expected).
Fields of papers citing papers by Eric Vuillemin
This network shows the impact of papers produced by Eric Vuillemin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Vuillemin. The network helps show where Eric Vuillemin may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Vuillemin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 256 | |
| 2 | 1993 | 124 | |
| 3 | 1996 | 30 | |
| 4 | 1994 | 10 | |
| 5 | [Seraspenide (acetylSDKP): phase I-II trial study of inhibitor of hematopoiesis protects against toxicity of aracytine and ifosfamide monochemotherapies]. | 1992 | 9 |
| 6 | 1993 | 8 | |
| 7 | 1995 | 8 | |
| 8 | 1995 | 7 | |
| 9 | 1994 | 6 | |
| 10 | 1998 | 6 | |
| 11 | 1994 | 5 | |
| 12 | 1998 | 5 | |
| 13 | 2014 | 5 | |
| 14 | 2016 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 1993 | 1 | |
| 17 | 1993 | 1 | |
| 18 | 1994 | 1 | |
| 19 | 1998 | 1 | |
| 20 | 2010 | 1 |
About Eric Vuillemin
Eric Vuillemin is a scholar working on Oncology, Otorhinolaryngology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Biological Psychiatry, having authored 21 papers that have together received 492 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (8 papers), Cancer Immunotherapy and Biomarkers (2 papers), Head and Neck Cancer Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Gastrointestinal Tumor Research and Treatment (1 paper), Neutropenia and Cancer Infections (1 paper), Chemotherapy-induced organ toxicity mitigation (1 paper) and Cancer survivorship and care (1 paper). The work is most often cited by research in Oncology (331 citations), Cancer Research (109 citations), Biological Psychiatry (5 citations), Otorhinolaryngology (11 citations) and Dermatology (15 citations). Eric Vuillemin has collaborated with scholars based in France. Frequent co-authors include Mo�se Namer, D. Serin, Stéphane Culine, Veronique C Dieras, Jean‐François Morère, P. Fumoleau, David Khayat, François Montestruc, Hubert Orfeuvre and Thierry Lesimple. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Clinical & Experimental Immunology, Psycho-Oncology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.